Figure 1
From: Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer

Diagramic chart of patient selection and analysis.
From: Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer
Diagramic chart of patient selection and analysis.